Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

BACKGROUND Ultrasound can cause microbubble destruction. If microbubbles are administered as a continuous infusion, then their destruction within the myocardium and measurement of their myocardial reappearance rate at steady state will provide a measure of mean myocardial microbubble velocity. Conversely, measurement of their myocardial concentration at steady state will provide an assessment of microvascular cross-sectional area. Myocardial blood flow (MBF) can then be calculated from the product of the two. METHODS AND RESULTS Ex vivo and in vitro experiments were performed in which either flow was held constant and pulsing interval (interval between microbubble destruction and replenishment) was altered, or vice versa. In vivo experiments were performed in 21 dogs. In group 1 dogs (n=7), MBF was mechanically altered in a model in which coronary blood volume was constant. In group 2 dogs (n=5), MBF was altered by direct coronary infusions of vasodilators. In group 3 dogs (n=9), non-flow-limiting coronary stenoses were created, and MBF was measured before and after the venous administration of a coronary vasodilator. In all experiments, microbubbles were delivered as a constant infusion, and myocardial contrast echocardiography was performed using different pulsing intervals. The myocardial video intensity versus pulsing interval plots were fitted to an exponential function: y=A(1-e[-betat]), where A is the plateau video intensity reflecting the microvascular cross-sectional area, and beta reflects the rate of rise of video intensity and, hence, microbubble velocity. Excellent correlations were found between flow and beta, as well as flow and the product of A and beta. CONCLUSIONS MBF can be quantified with myocardial contrast echocardiography during a venous infusion of microbubbles. This novel approach has potential for measuring tissue perfusion in any organ accessible to ultrasound.

[1]  Sanjiv Kaul,et al.  Quantification of Myocardial Perfusion With Myocardial Contrast Echocardiography During Left Atrial Injection of Contrast: Implications for Venous Injection , 1994, Circulation.

[2]  S. Kaul,et al.  Quantification of Images Obtained During Myocardial Contrast Echocardiography , 1994, Echocardiography.

[3]  Charles T. Lancée,et al.  Higher harmonics of vibrating gas-filled microspheres. Part two: measurements , 1994 .

[4]  S. Kaul,et al.  Interactions between microbubbles and ultrasound: in vitro and in vivo observations. , 1997, Journal of the American College of Cardiology.

[5]  A R Jayaweera,et al.  Coronary and myocardial blood volumes: noninvasive tools to assess the coronary microcirculation? , 1997, Circulation.

[6]  T. Porter,et al.  Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. , 1996, Journal of the American College of Cardiology.

[7]  M. Kern,et al.  Restoration of normal phasic flow velocity after multiple coronary artery stent placement. , 1994, American heart journal.

[8]  V L Newhouse,et al.  Simulated capillary blood flow measurement using a nonlinear ultrasonic contrast agent. , 1991, Ultrasonic imaging.

[9]  A R Jayaweera,et al.  Myocardial contrast echocardiography and the transmural distribution of flow: a critical appraisal during myocardial ischemia not associated with infarction. , 1992, Journal of the American College of Cardiology.

[10]  F. Klocke,et al.  First‐Pass Entry of Nonionic Contrast Agent Into the Myocardial Extravascular Space: Effects on Radiographic Estimates of Transit Time and Blood Volume , 1991, Circulation.

[11]  S. Kaul,et al.  Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiographic contrast agent, during acute myocardial infarction. , 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  S. Kaul,et al.  In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. , 1994, Circulation research.

[13]  V. Newhouse,et al.  Simulated Capillary Blood Flow Measurement Using a Nonlinear Ultrasonic Contrast Agent1 , 1992 .

[14]  S. Kaul,et al.  Transpulmonary transit of microbubbles during contrast echocardiography: implications for estimating cardiac output and pulmonary blood volume. , 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  Nico de Jong,et al.  Acoustic properties of ultrasound contrast agents , 1993 .

[16]  G S Kassab,et al.  Morphometry of pig coronary venous system. , 1994, The American journal of physiology.

[17]  P. Burns.  Harmonic imaging with ultrasound contrast agents. , 1996, Clinical radiology.

[18]  S. Kaul,et al.  Changes in myocardial blood volume with graded coronary stenosis. , 1997, The American journal of physiology.

[19]  G. J. Crystal,et al.  Small vessel and total coronary blood volume during intracoronary adenosine. , 1981, The American journal of physiology.

[20]  O. Amtorp,et al.  Effect of intracoronary adenosine upon regional blood flow, microvascular blood volume and hematocrit in canine myocardium. , 1984, International journal of microcirculation, clinical and experimental.

[21]  S. Kaul,et al.  Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second-generation echocardiographic contrast agent. , 1997, Circulation.

[22]  E L Ritman,et al.  Myocardial blood flow estimated by synchronous, multislice, high-speed computed tomography. , 1989, IEEE transactions on medical imaging.

[23]  S. Kaul,et al.  Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography. , 1997, Circulation.

[24]  S. Kaul,et al.  Assessment of Risk Area During Coronary Occlusion and Infarct Size After Reperfusion With Myocardial Contrast Echocardiography Using Left and Right Atrial Injections of Contrast , 1993, Circulation.

[25]  J. Y. Yang,et al.  Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist. , 1996, Circulation.